Brown DM - Search Results

1

Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration.

Brown DM, Tuomi L, Shapiro H; Pier Study Group. Brown DM, et al. Retina. 2013 Jan;33(1):23-34. doi: 10.1097/IAE.0b013e318263cedf. Retina. 2013. PMID: 23073338 Clinical Trial.

2

Long-term stability of circumferential silicone sponge scleral buckling exoplants.

Brown DM, Beardsley RM, Fish RH, Wong TP, Kim RY. Brown DM, et al. Retina. 2006 Jul-Aug;26(6):645-9. doi: 10.1097/01.iae.0000236473.63819.f4. Retina. 2006. PMID: 16829806

3

Ranibizumab for neovascular age-related macular degeneration.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group. Rosenfeld PJ, et al. Among authors: brown dm. N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481. N Engl J Med. 2006. PMID: 17021318 Free article. Clinical Trial.

4

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S; ANCHOR Study Group. Brown DM, et al. N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655. N Engl J Med. 2006. PMID: 17021319 Free article. Clinical Trial.

5

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, Fong DS, Bressler NM, Danis RP, Kinyoun JL, Nguyen QD, Bhavsar AR, Gottlieb J, Pieramici DJ, Rauser ME, Apte RS, Lim JI, Miskala PH. Diabetic Retinopathy Clinical Research Network, et al. Among authors: brown dm. Ophthalmology. 2007 Mar;114(3):525-36. doi: 10.1016/j.ophtha.2006.06.052. Epub 2006 Nov 21. Ophthalmology. 2007. PMID: 17123615 Free PMC article. Clinical Trial.

6

Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients.

Brown DM, Regillo CD. Brown DM, et al. Am J Ophthalmol. 2007 Oct;144(4):627-37. doi: 10.1016/j.ajo.2007.06.039. Am J Ophthalmol. 2007. PMID: 17893015 Review.

7

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results.

Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, Schneider S, Acharya NR. Kaiser PK, et al. Among authors: brown dm. Am J Ophthalmol. 2007 Dec;144(6):850-857. doi: 10.1016/j.ajo.2007.08.012. Epub 2007 Oct 22. Am J Ophthalmol. 2007. PMID: 17949673 Clinical Trial.

8

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.

Regillo CD, Brown DM, Abraham P, Yue H, Ianchulev T, Schneider S, Shams N. Regillo CD, et al. Among authors: brown dm. Am J Ophthalmol. 2008 Feb;145(2):239-248. doi: 10.1016/j.ajo.2007.10.004. Am J Ophthalmol. 2008. PMID: 18222192 Clinical Trial.

9

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Brown DM, et al. Ophthalmology. 2009 Jan;116(1):57-65.e5. doi: 10.1016/j.ophtha.2008.10.018. Ophthalmology. 2009. PMID: 19118696 Clinical Trial.

10

Selected clinical comparisons of spectral domain and time domain optical coherence tomography.

Luviano DM, Benz MS, Kim RY, Fish RH, Wong TP, Kegley EN, Brown DM. Luviano DM, et al. Among authors: brown dm. Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):325-8. doi: 10.3928/15428877-20090430-20. Ophthalmic Surg Lasers Imaging. 2009. PMID: 19485303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results